The Innovative Medicines Initiative (IMI) has published a full list of topics currently being considered for inclusion in IMI2 – Call 20. IMI’s next call for proposals is set to feature topics on cancer, tuberculosis, psoriasis, drugs based on proteins, and vaccines. The topics are:
Topic 1: Early diagnosis, prediction of radiographic outcomes and development of rational, personalised treatment strategies to improve long-term outcomes in psoriatic arthritis
Topic 2: Innovations to accelerate vaccine development and manufacture
Topic 3: Real-world clinical implementation of liquid biopsy
Topic 4: Tumour plasticity
Topic 5: Proton versus photon therapy for oesophageal cancer
Topic 6: Handling of protein drug products and stability concerns
Topic 7: Academia and industry united innovation and treatment for tuberculosis
The draft topic texts have been published online on the Future Topics page of the IMI website. Although the texts are indicative and could change in the coming weeks, the information will allow potential applicants to start building a consortium and putting together a proposal. Topics 1, 4 and 7 explicitly mention biomedical imaging in the call texts and are of particular interest for research active in biomedical imaging.
More information is available on the Innovative Medicines Initiative website:
Upcoming funding opportunities: https://www.imi.europa.eu/news-events/newsroom/find-out-about-imis-future-funding-opportunities
Future Topics: https://www.imi.europa.eu/apply-funding/future-topics